US approves first new Alzheimer’s drug in 20 years

By | June 8, 2021

In March 2019, late-stage international trials of aducanumab, involving about 3,000 patients, were halted when analysis showed the drug, given as a monthly infusion, was not better at slowing the deterioration of memory and thinking problems than a dummy drug.

BBC News – Health

Read More:  20 years after 9/11, we face another tragedy